Oct 21, 2020
Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS)
Oct 02, 2020
Pharming announces positive data from paediatric clinical trial with RUCONEST®
Aug 17, 2020
Pharming announces the publication of data from a compassionate use programme of RUCONEST® in COVID-19 patients in a peer-reviewed journal
Aug 10, 2020
Pharming announces enrolment of first patient in multinational clinical trial for the treatment of COVID-19 with RUCONEST®
Jul 30, 2020
Pharming Group reports financial results for the first half of 2020
May 20, 2020
Pharming Group announces the nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors
May 20, 2020
Pharming Reports on Annual General Meeting of Shareholders
May 16, 2020
Pharming celebrates “hae day :-)”
May 14, 2020
Pharming Group reports financial results for the first quarter of 2020
Apr 30, 2020
Pharming receives European Commission approval for treatment of acute hereditary angioedema attacks in children with RUCONEST®
Displaying 11 - 20 of 29